Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

An NF-kB site in the IgH3' enhancer is required for the deregulation of c-myc in Burkitt's Lymphoma

An NF-kB site in the IgH3' enhancer is required for the deregulation of c-myc in Burkitt's Lymphoma. American Association for Cancer Research 91st Proceedings. 2000; 41:628.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.